Gilead’s Livdelzi Shows ALP Reduction and Itch Relief in PBC
November 7, 2025
Gilead Sciences, Inc. shared new long‑term data reinforcing the safety and effectiveness of Livdelzi (seladelpar) for people living with Primary Biliary Cholangitis (PBC). The findings